DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.

Overview
Date Founded

2009

Headquarters

999 West Broadway,Suite 720,Vancouver, BC V5Z 1K5

Type of Company

Public

Employees (Worldwide)

17

Industries

Pharmaceuticals
Retail: Drug Stores

Company Description

DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Executives & Employees

Co-Founder

President, Director & Chief Executive Officer

Chief Financial Officer, Secretary & Chief Accounting Officer

Board of Directors

Chief Financial Officer & Senior Vice President, Finance at Heron Therapeutics, Inc.

Editor-in-Chief at Molecular Cancer Therapeutics

President, Director & Chief Executive Officer at DelMar Pharmaceuticals, Inc.

Senior Portfolio Manager at Falcon Point Capital LLC

Former Chief Executive Officer at Provincial Health Services Authority

Paths to DelMar Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
DelMar Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Sabby Capital focuses on investments in the healthcare sector.

Details Hidden

Sabby Capital focuses on investments in the healthcare sector.

Recent Transactions
Details Hidden

DelMar Pharmaceuticals, Inc. issued USD Common Stock and Warrants

Details Hidden

DelMar Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

DelMar Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onDelMar Pharmaceuticals, Inc. raised money in a private placement transaction

Investment Advisor

Advised onDelMar Pharmaceuticals, Inc. raised money in a private placement transaction

Legal Advisor

Advised onDelMar Pharmaceuticals, Inc. issued USD Common Stock and Warrants

Legal Advisor

Advised onDelMar Pharmaceuticals, Inc. purchases Del Mar Pharmaceuticals (BC) Ltd.

Executive Managing Director-Investment Banking

Advised onDelMar Pharmaceuticals, Inc. issued USD Common Stock and Warrants

Escrow Agent

Advised onDelMar Pharmaceuticals, Inc. issued USD Common Stock and Warrants

Advisors & Consultants
Advisor

Founder at Centrexion Therapeutics Corp.

Advisor

Former Member, Healthcare Equity Research Team at BMO Capital Markets Corp. (Canada)

Consultant

Former President & Chief Executive Officer at Inimex Pharmaceuticals, Inc.

Key Stats and Financials As of 2019
Market Capitalization
$14.3M
Total Enterprise Value
$4.58M
Earnings Per Share
$-3.16
Revenue
$0
Net Profit
$-8.05M
EBITDA
$-8.38M
Total Equity
$1.97M
Total Debt
$0
TEVNet Income
-0.57x
Debt TEV
0x
Suppliers
Guangxi Wuzhou Zhongheng Group Co., Ltd. Pharmaceuticals | Zhangzhou, GG

Guangxi Wuzhou Zhongheng Group Co., Ltd. engages in the pharmaceutical manufacturing, food production, and real estate development and management. The pharmaceutical manufacturing industry's core business includes research and development, production, sale, and service of Chinese medicines and injection products. The company was founded on April 1, 1993 and is headquartered in Zhangzhou, China.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Agios Pharmaceuticals, Inc. Pharmaceuticals - Cambridge, Massachusetts

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Middlesex

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by DelMar Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of DelMar Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and DelMar Pharmaceuticals, Inc..